Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1971 1
1978 1
1979 1
1980 2
1981 5
1982 6
1983 3
1984 1
1985 1
1986 3
1987 4
1988 8
1989 3
1990 8
1991 11
1992 6
1993 10
1994 9
1995 18
1996 14
1997 11
1998 16
1999 21
2000 25
2001 27
2002 32
2003 22
2004 34
2005 39
2006 50
2007 72
2008 61
2009 79
2010 77
2011 102
2012 108
2013 124
2014 115
2015 99
2016 113
2017 79
2018 79
2019 96
2020 113
2021 119
2022 98
2023 80
2024 67
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,847 results

Results by year

Filters applied: . Clear all
Page 1
PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer.
Kang YK, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, Ryu MH, Rha SY, Chung IJ, Kim IH, Oh SC, Park YS, Son T, Jung MR, Heo MH, Kim HK, Park C, Yoo CH, Choi JH, Zang DY, Jang YJ, Sul JY, Kim JG, Kim BS, Beom SH, Cho SH, Ryu SW, Kook MC, Ryoo BY, Kim HK, Yoo MW, Lee NS, Lee SH, Kim G, Lee Y, Lee JH, Noh SH. Kang YK, et al. Among authors: park yk. J Clin Oncol. 2021 Sep 10;39(26):2903-2913. doi: 10.1200/JCO.20.02914. Epub 2021 Jun 16. J Clin Oncol. 2021. PMID: 34133211 Free PMC article. Clinical Trial.
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirzén F, Noh SH; CLASSIC trial investigators. Bang YJ, et al. Among authors: park yk. Lancet. 2012 Jan 28;379(9813):315-21. doi: 10.1016/S0140-6736(11)61873-4. Epub 2012 Jan 7. Lancet. 2012. PMID: 22226517 Clinical Trial.
In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis.
Roper J, Tammela T, Cetinbas NM, Akkad A, Roghanian A, Rickelt S, Almeqdadi M, Wu K, Oberli MA, Sánchez-Rivera FJ, Park YK, Liang X, Eng G, Taylor MS, Azimi R, Kedrin D, Neupane R, Beyaz S, Sicinska ET, Suarez Y, Yoo J, Chen L, Zukerberg L, Katajisto P, Deshpande V, Bass AJ, Tsichlis PN, Lees J, Langer R, Hynes RO, Chen J, Bhutkar A, Jacks T, Yilmaz ÖH. Roper J, et al. Among authors: park yk. Nat Biotechnol. 2017 Jun;35(6):569-576. doi: 10.1038/nbt.3836. Epub 2017 May 1. Nat Biotechnol. 2017. PMID: 28459449 Free PMC article.
Spinal angiolipoma--case report.
Chotai S, Hur JS, Moon HJ, Kwon TH, Park YK, Kim JH. Chotai S, et al. Among authors: park yk. Neurol Med Chir (Tokyo). 2011;51(7):539-42. doi: 10.2176/nmc.51.539. Neurol Med Chir (Tokyo). 2011. PMID: 21785253 Free article.
Health benefits of fucoxanthin in the prevention of chronic diseases.
Bae M, Kim MB, Park YK, Lee JY. Bae M, et al. Among authors: park yk. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Nov;1865(11):158618. doi: 10.1016/j.bbalip.2020.158618. Epub 2020 Jan 10. Biochim Biophys Acta Mol Cell Biol Lipids. 2020. PMID: 31931174 Review.
Antinuclear antibodies in infectious diseases.
Im JH, Chung MH, Park YK, Kwon HY, Baek JH, Lee SY, Lee JS. Im JH, et al. Among authors: park yk. Infect Dis (Lond). 2020 Mar;52(3):177-185. doi: 10.1080/23744235.2019.1690676. Epub 2019 Nov 12. Infect Dis (Lond). 2020. PMID: 31718355
1,847 results